InsidersTradesSigma
Explore the complete record of transactions filed by Auberton-Herve Andre-Jacques, Director. Officer active across 2 companies, notably Chavant Capital Acquisition Corp.. Cumulatively, 2 filings have been logged. Activity tracked since 24 February 2022. The latest transaction was disclosed on 15 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
André-Jacques Auberton-Hervé is a Board Member at Chavant Capital Acquisition Corp. and Bionik Laboratories Corp. He contributes to the governance of these companies by providing his expertise in innovation and technology. His experience allows him to influence the strategy and direction of both companies.